课题基金 / 基金详情

Analyses of biological significance of GPI-anchored protein CD109 in mouse development

Analyses of biological significance of GPI-anchored protein CD109 in mouse development
GPI锚定蛋白CD109在小鼠发育中的生物学意义分析
批准号:
21590435
负责人:
MURAKUMO Yoshiki
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

MURAKUMO Yoshiki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We generated CD109 knockout mouse to assess biological significance of GPI-anchored protein CD109 in mouse development. In wild-type mouse, CD109 expression was detected in basal and suprabasal region of the epidermis and seminiferous tubules of the testis. CD109./. mice could be alive and showed transient hair-loss from postnatal day 7(P7) to P28. CD109./. male and female mice were fertile. Histopathological analyses revealed that epidermal hyperplasia was detected in CD109./. mice from P7 to P70, and ectatic hair follicles were apparent from p14 to p21. Since epidermal hyperplasia was seen in dorsal skin epidermis, which does not have hair and hair follicles, we thought that CD109-deficiency develops epidermal hyperplasia, which leads to ectatic hair follicle and hair-loss. Immunohistochemical analyses revealed that STAT3 phosphorylation was apparently upregulated compaired with wild-type mice, suggesting that STAT3 signaling may be associated with epidermal hyperplasia of CD109./. mice. Next, we tried to detect secreted CD109 and to identify its interaction partners in the serum of CD109 transgenic mice. Secreted CD109 in mouse serum was detected by Western blotting, however, we could not identify candidates of CD109-interaction proteins in this experiment. Then, we attempted to identify CD109-interaction proteins in the medium of CD109-overexpressing culture cells. We successfully identified a candidate of CD109-interaction protein in this experiment, and now we are investigating biological significance of the interaction between CD109 and the interaction protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.humpath.2010.09.015
发表时间: 2011-06
期刊: Human pathology
影响因子: 3.3
作者: [Shoji Saito;Y. Murakumo;T. Tsuzuki;Atsushi Dambara;Takuya Kato;A. Enomoto;N. Asai;S. Maruyama;S. Matsuo;Masahide Takahashi]
通讯作者: Shoji Saito;Y. Murakumo;T. Tsuzuki;Atsushi Dambara;Takuya Kato;A. Enomoto;N. Asai;S. Maruyama;S. Matsuo;Masahide Takahashi
DOI: 10.1091/mbc.e10-08-0724
发表时间: 2011-03-15
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [Matsushita E, Asai N, Enomoto A, Kawamoto Y, Kato T, Mii S, Maeda K, Shibata R, Hattori S, Hagikura M, Takahashi K, Sokabe M, Murakumo Y, Murohara T, Takahashi M]
通讯作者: Takahashi M
GPIアンカー型膜蛋白CD109のヒト腫瘍における発現とその生物学的意義
GPI锚定膜蛋白CD109在人肿瘤中的表达及其生物学意义
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [石川文洋, 白橋雅人, 円谷健, 藤井郁雄, 村雲芳樹]
通讯作者: 村雲芳樹
膀胱癌におけるCD109発現の臨床病理学的特徴との関連性の検討
膀胱癌CD109表达与临床病理特征的关系探讨
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [伊藤智広, 藤田泰典, 伊藤美佳子, 増田章男, 市原正智, 小島俊男, 野澤義則, 大野欽司, 伊藤雅史, 伊藤智広, 市原正智, 祖父江沙矢加, 山本純矢, 大内靖夫, 喬善楼, Murakumo Y, 三井伸二, 村雲芳樹, 萩倉美奈子]
通讯作者: 萩倉美奈子
47
    Significance of REV7 for germ cell maintenance and spermatogenesis
    • 批准号:
      24590479
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    Involvement of DNA repair protein REV7 in cell proliferation, mobility and organogenesis
    • 批准号:
      19590387
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    Generation and Characterization of Knockout Mice Targeting REV7 gene, which is involved in DNA damage tolerance
    • 批准号:
      17590340
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    Characterization of human REV proteins which are involved in mutagenesis
    • 批准号:
      14570185
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2002
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    国内基金
    海外基金
    CD109/TGF-β1轴调控鼻黏膜基底细胞分化在CRSwNP组织纤维化中的作用机制
    • 批准号:
      2025JJ60718
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郜儒
    • 依托单位:
    CD109通过增强β-catenin稳定性维持肿瘤干细胞干性促进鼻咽癌转移的研究
    • 批准号:
      82303533
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      胥洪鹃
    • 依托单位:
    CD109通过激活Wnt/β-catenin通路增强肿瘤干细胞干性诱导鼻咽癌耐药及靶向治疗研究
    • 批准号:
      2023JJ41007
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      胥洪鹃
    • 依托单位:
    CD109通过调节血管内皮细胞EGFR-MEKK3-KLF4信号传导网络对脑海绵状血管畸形的作用机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      55万元
    • 批准年份:
      2021
    • 负责人:
      刘炬
    • 依托单位: